APGE Long Call Strategy
APGE (Apogee Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
APGE (Apogee Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.19B, a beta of 0.69 versus the broader market, a 52-week range of 34.34-95.315, average daily share volume of 880K, a public-listing history dating back to 2023, approximately 196 full-time employees. These structural characteristics shape how APGE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.69 indicates APGE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on APGE?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current APGE snapshot
As of May 15, 2026, spot at $81.32, ATM IV 70.60%, IV rank 14.06%, expected move 20.24%. The long call on APGE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this long call structure on APGE specifically: APGE IV at 70.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a APGE long call, with a market-implied 1-standard-deviation move of approximately 20.24% (roughly $16.46 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated APGE expiries trade a higher absolute premium for lower per-day decay. Position sizing on APGE should anchor to the underlying notional of $81.32 per share and to the trader's directional view on APGE stock.
APGE long call setup
The APGE long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With APGE near $81.32, the first option leg uses a $80.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed APGE chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 APGE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $80.00 | $9.65 |
APGE long call risk and reward
- Net Premium / Debit
- -$965.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$965.00
- Breakeven(s)
- $89.65
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
APGE long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on APGE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$965.00 |
| $17.99 | -77.9% | -$965.00 |
| $35.97 | -55.8% | -$965.00 |
| $53.95 | -33.7% | -$965.00 |
| $71.93 | -11.6% | -$965.00 |
| $89.91 | +10.6% | +$25.60 |
| $107.89 | +32.7% | +$1,823.52 |
| $125.86 | +54.8% | +$3,621.44 |
| $143.84 | +76.9% | +$5,419.36 |
| $161.82 | +99.0% | +$7,217.28 |
When traders use long call on APGE
Long calls on APGE express a bullish thesis with defined risk; traders use them ahead of APGE catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
APGE thesis for this long call
The market-implied 1-standard-deviation range for APGE extends from approximately $64.86 on the downside to $97.78 on the upside. A APGE long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current APGE IV rank near 14.06% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on APGE at 70.60%. As a Healthcare name, APGE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to APGE-specific events.
APGE long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. APGE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move APGE alongside the broader basket even when APGE-specific fundamentals are unchanged. Long-premium structures like a long call on APGE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current APGE chain quotes before placing a trade.
Frequently asked questions
- What is a long call on APGE?
- A long call on APGE is the long call strategy applied to APGE (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With APGE stock trading near $81.32, the strikes shown on this page are snapped to the nearest listed APGE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are APGE long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the APGE long call priced from the end-of-day chain at a 30-day expiry (ATM IV 70.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$965.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a APGE long call?
- The breakeven for the APGE long call priced on this page is roughly $89.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current APGE market-implied 1-standard-deviation expected move is approximately 20.24%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on APGE?
- Long calls on APGE express a bullish thesis with defined risk; traders use them ahead of APGE catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current APGE implied volatility affect this long call?
- APGE ATM IV is at 70.60% with IV rank near 14.06%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.